GB201906830D0 - Delivery of bacteria-derived outer membrane vesicles - Google Patents

Delivery of bacteria-derived outer membrane vesicles

Info

Publication number
GB201906830D0
GB201906830D0 GBGB1906830.3A GB201906830A GB201906830D0 GB 201906830 D0 GB201906830 D0 GB 201906830D0 GB 201906830 A GB201906830 A GB 201906830A GB 201906830 D0 GB201906830 D0 GB 201906830D0
Authority
GB
United Kingdom
Prior art keywords
bacteria
delivery
outer membrane
membrane vesicles
derived outer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1906830.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadram Institute
Original Assignee
Quadram Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadram Institute filed Critical Quadram Institute
Priority to GBGB1906830.3A priority Critical patent/GB201906830D0/en
Publication of GB201906830D0 publication Critical patent/GB201906830D0/en
Priority to EP20736398.7A priority patent/EP3969042A2/en
Priority to JP2021568646A priority patent/JP2022533976A/ja
Priority to US17/595,330 priority patent/US12527852B2/en
Priority to PCT/GB2020/051204 priority patent/WO2020229846A2/en
Priority to US19/421,676 priority patent/US20260183376A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
GBGB1906830.3A 2019-05-15 2019-05-15 Delivery of bacteria-derived outer membrane vesicles Ceased GB201906830D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1906830.3A GB201906830D0 (en) 2019-05-15 2019-05-15 Delivery of bacteria-derived outer membrane vesicles
EP20736398.7A EP3969042A2 (en) 2019-05-15 2020-05-15 Delivery of bacteria-derived outer membrane vesicles
JP2021568646A JP2022533976A (ja) 2019-05-15 2020-05-15 バクテリア由来の外膜小胞の供給
US17/595,330 US12527852B2 (en) 2019-05-15 2020-05-15 Delivery of bacteria-derived outer membrane vesicles
PCT/GB2020/051204 WO2020229846A2 (en) 2019-05-15 2020-05-15 Delivery of Bacteria-Derived Outer Membrane Vesicles
US19/421,676 US20260183376A1 (en) 2019-05-15 2025-12-16 Delivery of bacteria-derived outer membrane vesicles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1906830.3A GB201906830D0 (en) 2019-05-15 2019-05-15 Delivery of bacteria-derived outer membrane vesicles

Publications (1)

Publication Number Publication Date
GB201906830D0 true GB201906830D0 (en) 2019-06-26

Family

ID=67384734

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1906830.3A Ceased GB201906830D0 (en) 2019-05-15 2019-05-15 Delivery of bacteria-derived outer membrane vesicles

Country Status (5)

Country Link
US (2) US12527852B2 (cg-RX-API-DMAC10.html)
EP (1) EP3969042A2 (cg-RX-API-DMAC10.html)
JP (1) JP2022533976A (cg-RX-API-DMAC10.html)
GB (1) GB201906830D0 (cg-RX-API-DMAC10.html)
WO (1) WO2020229846A2 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114672507B (zh) * 2022-03-22 2024-04-16 浙江工业大学 一种可递呈多个异源肽或蛋白质的细菌外膜囊泡及其构建方法和应用
CN119875903B (zh) * 2025-01-13 2025-09-19 南昌大学 一种基于细菌外膜囊泡的抗生素载体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE040658T2 (hu) * 2010-04-07 2019-03-28 California Inst Of Techn Vivõanyag vegyület mukózus membránhoz juttatásához és kapcsolódó készítmények, eljárások és rendszerek
GB201607510D0 (en) * 2016-04-29 2016-06-15 Inst Of Food Res The Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMV) for delivery to the GI-tract
GB201817194D0 (en) 2018-10-22 2018-12-05 Quadram Inst Bioscience Gut bacteria derived microvesicles for vaccine delivery

Also Published As

Publication number Publication date
US12527852B2 (en) 2026-01-20
WO2020229846A2 (en) 2020-11-19
US20260183376A1 (en) 2026-07-02
EP3969042A2 (en) 2022-03-23
JP2022533976A (ja) 2022-07-27
US20220175901A1 (en) 2022-06-09
WO2020229846A3 (en) 2021-01-14

Similar Documents

Publication Publication Date Title
IL277344A (en) Extracellular vesicles containing agonist-STING
GB2582695B (en) Membrane
IL261490A (en) Medical membrane vesicles
GB201907302D0 (en) Delivery system
SG11202100870UA (en) Extracellular vesicles for inhalation
GB2561956B (en) Aerosol delivery system
GB201718681D0 (en) Protein engineered extracellular vesicles
SG11202102688PA (en) Surface modified extracellular vesicles
PL3693325T3 (pl) System dostawczy
GB201917438D0 (en) Aerosol delivery system
IL275458A (en) Therapeutic antibodies to the inner ear by AAV-mediated delivery
IL283627A (en) Improved transport of large materials
GB201812992D0 (en) Liposomes
PT4004079T (pt) Produção de sistemas de poliuretano
IL284761A (en) Modulators of yap1 expression
EP3966400C0 (de) Baubahn
IL287370A (en) Extracellular vesicles derived from activated t cells containing car
IL290039A (en) Platelet assisted delivery of therapeutic compounds
GB2582606B (en) Delivery of radiotherapy
GB201903873D0 (en) Enhanced transfection
EP3277288A4 (en) Guanidinoglycoside-mediated liposome-based delivery of therapeutics
GB201808285D0 (en) Labelling of extracellular vesicles
GB201912834D0 (en) Aerosol delivery system
GB201908661D0 (en) Assembled respirator
HK40062193A (en) Improved delivery of large agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)